AI in medical communications

Integration of AI in Medical Communications: A Roadmap

AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
How Can Preprints Drive Trust In Science?

How Can Preprints Drive Trust in Science?

By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...
Strategic publication planning: A handy infographic for medical affairs

Strategic Publication Planning: Infographic for Medical Affairs

Here's a quick and easy-to-follow guide on for medical affairs teams on the what, how...
Pexels Alexander Suhorucov

Plain Language Summary Development in Japan: Current State and Challenges

This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
FDA social media usage guidelines

US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies

This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...

Learn more ABOUT our company.